Let’s continue to work together to advocate for more PC patient knowledge and education, which leads to more patient empowerment, better outcomes and higher patient satisfaction with their own outcome. The three FUNDAMENTALS for AS listed earlier in this thread are a great start, but there may be more.
In re-reading through this thread again, one important, fundamental aspect which seems to escape many of the commenters is just how
large the population of men is who may be candidates for Active Surveillance. Some comments implied that it might be a small number of newly diagnosed men who are eligible for AS. The correct answer is that no matter how you slice it, it is a huge number of men. Let’s look at some data…
In the recently published work “Gleason Grading of Prostate Cancer,” the authors looked at contemporary prevalence of primary and secondary Gleason grades—a contemporary view is important because the original Gleason classifications have evolved. 77.3% of newly diagnosed cases had a primary Gleason grade of 3. Here’s the breakdown:
3+2: 0.7%
3+3: 40.3%
3+4: 32.5%
3+5: 3.8%
Total with
primary Gleason grade of 3: 77.3%
The Johns Hopkins AS program is recognized as probably the most restrictive, and initially only accepted 3+3 cases, so the most restrictive program might only accept up to about
40% of all newly diagnosed men based on this data.
Most of the other major programs are
less restrictive than Johns Hopkins and include a subset of the 3+4 favorable intermediate risk men. We see from the data above, looking only at Gleason scoring, that might be as high as 73.5% of all newly diagnosed men (based on 0.7% + 40.3% + 32.5%).
HOWEVER, men in the favorable intermediate risk category have more restrictive criteria in the some of the other case characteristics which might exclude them. An article in the PC Infolink today discusses a new report published this week which pegs the upper threshold of all newly diagnosed men at 67% being eligible for the less restrictive AS programs. (Read the article for your own complete understanding: http://prostatecancerinfolink.net/2015/09/03/21890/)
So, depending on the “restrictiveness” of the AS program, somewhere roughly between about
40% and 67% of all newly diagnosed are eligible for Active Surveillance. That’s a huge number, and it’s clearly the largest single categorization of newly diagnosed men.
So, I would propose this summary statement to be added, along with the three previously documented “FUNDAMENTALS” in this thread, to the “Newly diagnosed…” thread:
AS FUNDAMENTAL #4:
A huge percentage of newly diagnosed men are suitable for Active Surveillance as a first-line management strategy. Some AS programs are more restrictive than others, and there is currently no universally accepted formal protocol for AS entry, monitoring, or exit. Clinicians individually tailor a program of care to each individual case but based on common foundations. Using contemporary data of newly diagnosed cases in the US, somewhere between 40% and 67% of new PC cases are likely eligible for Active Surveillance, based on more and less restrictive program criteria.
Anyone else want to suggest another “AS FUNDAMENTAL” which might also benefit HW/PC newcomers?
Post Edited (JackH) : 9/3/2015 12:27:52 PM (GMT-6)